SCHEMBL4438581

SCHEMBL4438581

COc1ccc(OCCCCN2CCC(C(C(N)=O)(c3ccccc3)c3ccccc3)C2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 4/20 0.62
▸ KMT2A Q03164 3/20 0.57
▸ CYP2J2 P51589 1/20 0.52
▸ KCNH2 Q12809 2/20 0.51
▸ CHRM2 P08172 2/20 0.51
▸ CHRM3 P20309 2/20 0.51
▸ ADRB2 P07550 1/20 0.51
▸ CHRM4 P08173 1/20 0.51
▸ ADRB1 P08588 1/20 0.51
▸ CHRM5 P08912 1/20 0.51
▸ ADRA2A P08913 1/20 0.51
▸ CHRM1 P11229 1/20 0.51
▸ DRD2 P14416 1/20 0.51
▸ KCNE1 P15382 1/20 0.51
▸ ADRA2B P18089 1/20 0.51
▸ ADRA2C P18825 1/20 0.51
▸ HRH2 P25021 1/20 0.51
▸ HTR2A P28223 1/20 0.51
▸ SLC6A4 P31645 1/20 0.51
▸ ADRA1A P35348 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9357779 0.91 ACKR3 (0.68) ACKR3KMT2AKCNH2CHRM2CHRM3
SCHEMBL953884 0.91 ACKR3 (0.68) ACKR3KMT2AKCNH2CHRM2CHRM3
SCHEMBL953886 0.91 ACKR3 (0.68) ACKR3KMT2AKCNH2CHRM2CHRM3
SCHEMBL13590408 0.88 ACKR3 (0.59) ACKR3CYP2J2KCNH2CHRM2CHRM3
SCHEMBL9361705 0.87 ACKR3 (0.75) ACKR3KCNH2CHRM2CHRM3ADRB2
SCHEMBL9361710 0.87 ACKR3 (0.75) ACKR3KCNH2CHRM2CHRM3ADRB2
SCHEMBL13592297 0.86 CHRM3 (0.61) ACKR3CYP2J2KCNH2CHRM2CHRM3
SCHEMBL13590341 0.86 CHRM3 (0.61) ACKR3CYP2J2KCNH2CHRM2CHRM3
SCHEMBL13590478 0.86 CHRM3 (0.61) ACKR3CYP2J2KCNH2CHRM2CHRM3
SCHEMBL13590293 0.86 CHRM3 (0.61) ACKR3CYP2J2KCNH2CHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121594-A1 QUATERNARY AMMONIUM DIPHENYLMETHYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2009-11-25 — — EP disclosed
WO-2008103426-A1 QUATERNARY AMMONIUM DIPHENYLMETHYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2008-08-28 — — WO disclosed
Send feedback